← Open Payments lookup

KAJAL PATEL: Open Payments

NPI 1841987849 · HILLSBOROUGH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$491 in 22 payments from 9 companies in 2025. Trend: 2023 $86 · 2024 $394 · 2025 $491

Food & beverage: $491
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.2$143
Bayer Healthcare Pharmaceuticals Inc.5$93
Novo Nordisk Inc5$84
AstraZeneca Pharmaceuticals LP3$53
ABBVIE INC.2$35
Lundbeck LLC2$30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21
Axsome Therapeutics, Inc.1$15
Sumitomo Pharma America, Inc.1$15

Products named: REXULTI, Kerendia, Ozempic, FARXIGA, VRAYLAR, CAPLYTA, Rybelsus, Auvelity.

Industry payments across NJ — which companies pay providers there.